Verhoef LM, den Broeder N, Thurlings, et al. Ultra-low doses of rituximab or retreatment of rheumatoid arthritis: a randomised controlled non-inferiority trial. EULAR 2019; Madrid: Abstract LB0010.
Effectiviteit van rituximab, abatacept en tocilizumab bij anti-TNF-refractaire RA
mrt 2019 | RA